Back
ESC2025 Premium Access

Adiposity-related anthropometrics, cardiovascular outcomes, and finerenone in heart failure and chronic kidney disease with type 2 diabetes: a FINE-HEART analysis

Session: Challenges of managing obesity in cardiovascular disease
Topic: Obesity
Speaker: Doctor J. Ostrominski (Boston, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor John Ostrominski

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
2 presentations
0 follower

5 more presentations in this session

How excess fat affects cardiac electrophysiology: preclinical obesity, clinical obesity with cardiac arrhythmias and ECG features

Speaker: Doctor N. Zhang (Tianjin, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Childhood adiposity affects cardiac structure, function and disease risk in later life: evidence of a causal association

Speaker: Doctor D. Du (Beijing, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Beyond BMI: the predictive value of body roundness index for premature all-cause and cardiovascular mortality: a national cohort study of US adults under 65

Speaker: Doctor S. Abohashem (Boston, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Identification of patients eligible for treatment with semaglutide after an acute coronary syndrome according to guidelines recommendations

Speaker: Doctor A. Cordero (Alicante, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Implications of obesity and metabolic health on coronary heart disease: an analysis of 157,159 participants in the UK Biobank

Speaker: Doctor R. Ananda (Melbourne, AU)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Challenges of managing obesity in cardiovascular disease

Speakers: Doctor J. Ostrominski, Doctor N. Zhang, Doctor D. Du, Doctor S. Abohashem, Doctor A. Cordero...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources